AudioEye (AEYE) Stock Sinks As Market Gains: Here's Why — Negative
AEYE Zacks Investment Research — February 11, 2025AudioEye (AEYE) closed the most recent trading day at $18.41, moving -1.29% from the previous trading session.
AvidXchange Holdings, Inc. (AVDX) Stock Slides as Market Rises: Facts to Know Before You Trade — Negative
AVDX Zacks Investment Research — February 11, 2025AvidXchange Holdings, Inc. (AVDX) reachead $9.99 at the closing of the latest trading day, reflecting a -1.67% change compared to its last close.
Why Dream Finders Homes Inc. (DFH) Outpaced the Stock Market Today — Positive
DFH Zacks Investment Research — February 11, 2025In the most recent trading session, Dream Finders Homes Inc. (DFH) closed at $21.78, indicating a +0.69% shift from the previous trading day.
Air Industries (AIRI) Flat As Market Gains: What You Should Know — Positive
AIRI Zacks Investment Research — February 11, 2025Air Industries (AIRI) concluded the recent trading session at $4.23, signifying no movement from its prior day's close.
HP (HPQ) Outperforms Broader Market: What You Need to Know — Positive
HPQ Zacks Investment Research — February 11, 2025In the closing of the recent trading day, HP (HPQ) stood at $33.15, denoting a +1.01% change from the preceding trading day.
Diodes (DIOD) Q4 Earnings Lag Estimates — Negative
DIOD Zacks Investment Research — February 11, 2025Diodes (DIOD) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.51 per share a year ago.
Zillow (Z) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.20 per share a year ago.
Zillow Group (ZG) Lags Q4 Earnings Estimates — Negative
ZG Zacks Investment Research — February 11, 2025Zillow Group (ZG) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.20 per share a year ago.
Cardlytics, Inc. Shareholders with Large Losses Should Contact Robbins LLP for Information About the CDLX Class Action Lawsuit — Neutral
CDLX GlobeNewsWire — February 11, 2025SAN DIEGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Cardlytics, Inc. (NASDAQ: CDLX) securities between March 14, 2024 and August 7, 2024. Cardlytics operates an advertising platform in the U.S. and the U.K. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBU — Neutral
CRBU Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Caribou Biosciences, Inc. (NASDAQ:CRBU) between July 14, 2023 and July 16, 2024, both dates inclusive (the "Class Period"), of the important February 24, 2025 lead plaintiff deadline. SO WHAT: If you purchased Caribou securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Similarweb (SMWB) Reports Q4 Loss, Tops Revenue Estimates — Negative
SMWB Zacks Investment Research — February 11, 2025Similarweb (SMWB) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of $0.03. This compares to break-even earnings per share a year ago.
Compared to Estimates, Assurant (AIZ) Q4 Earnings: A Look at Key Metrics — Positive
AIZ Zacks Investment Research — February 11, 2025The headline numbers for Assurant (AIZ) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics — Positive
EW Zacks Investment Research — February 11, 2025Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
BlackLine (BL) Reports Q4 Earnings: What Key Metrics Have to Say — Positive
BL Zacks Investment Research — February 11, 2025The headline numbers for BlackLine (BL) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Avis Budget (CAR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates — Positive
CAR Zacks Investment Research — February 11, 2025The headline numbers for Avis Budget (CAR) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Compared to Estimates, Upstart (UPST) Q4 Earnings: A Look at Key Metrics — Positive
UPST Zacks Investment Research — February 11, 2025The headline numbers for Upstart (UPST) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Here's What Key Metrics Tell Us About Allison Transmission (ALSN) Q4 Earnings — Positive
ALSN Zacks Investment Research — February 11, 2025The headline numbers for Allison Transmission (ALSN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Agree Realty (ADC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates — Positive
ADC Zacks Investment Research — February 11, 2025The headline numbers for Agree Realty (ADC) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Exelixis (EXEL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates — Neutral
EXEL Zacks Investment Research — February 11, 2025While the top- and bottom-line numbers for Exelixis (EXEL) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Why Vital Farms (VITL) Outpaced the Stock Market Today — Positive
VITL Zacks Investment Research — February 11, 2025In the latest trading session, Vital Farms (VITL) closed at $35.71, marking a +0.85% move from the previous day.
